MTS Health Partners
MTS Health Partners, L.P. is a specialized investment bank based in New York City, founded in 1999. The firm focuses on providing corporate finance advisory services exclusively to the healthcare sector. Its range of services includes mergers and acquisitions, recapitalization, restructuring, fairness opinions, divestitures, and strategic advisory. MTS Health Partners has substantial experience working with both public and private healthcare companies, assisting them in privately negotiated financings across various structures and uses of funds. The firm has represented notable clients in the healthcare industry, demonstrating its capability in navigating complex financial transactions within this sector.
Top Stages
2 past transactions
Zymeworks
Post in 2018
Zymeworks Inc. is a clinical-stage biopharmaceutical company based in Vancouver, Canada, focused on the discovery, development, and commercialization of innovative biotherapeutics for cancer treatment. The company's lead candidates include ZW25, a bispecific antibody undergoing Phase I and II clinical trials for various tumors, including biliary tract and gastroesophageal adenocarcinomas, and ZW49, a bispecific antibody-drug conjugate in Phase I trials for advanced HER2-expressing cancers. Zymeworks employs a computational biotechnology approach, utilizing proprietary molecular modeling and simulation technologies to optimize therapeutic antibodies and other protein-based therapeutics. The company has established strategic partnerships with notable organizations such as Merck, Eli Lilly, and Bristol-Myers Squibb, as well as collaborations aimed at advancing antibody discovery and development. Founded in 2003, Zymeworks is dedicated to addressing unmet medical needs through its advanced therapeutic platforms and integrated drug development capabilities.
myNEXUS
Funding Round in 2014
myNEXUS, Inc. is a healthcare management company based in Brentwood, Tennessee, that specializes in technology-driven care management services. Founded in 2014, the company focuses on improving the health of individuals with chronic conditions by providing daily remote monitoring of their health status. This proactive approach enables timely responses to potential health issues, thereby minimizing unnecessary healthcare visits. myNEXUS primarily serves patients dealing with conditions such as congestive heart failure, diabetes, and hypertension, as well as those requiring health education, disease prevention, or care coordination. The company's digital health system, myLINK2Care, combines intelligent technology with compassionate care, while also offering benefits management services aimed at reducing readmission risks. By addressing the needs of insurers, employers, and family members, myNEXUS facilitates better health outcomes and enhances the quality of life for its patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.